Page last updated: 2024-11-11

vitamin u

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

Vitamin U: A vitamin found in green vegetables. It is used in the treatment of peptic ulcers, colitis, and gastritis and has an effect on secretory, acid-forming, and enzymatic functions of the intestinal tract. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

S-methyl-L-methioninate : A sulfonium betaine that is a conjugate base of S-methyl-L-methionine obtained by the deprotonation of the carboxy group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID10197842
CHEMBL ID2074824
CHEBI ID67050
SCHEMBL ID398004
MeSH IDM0022809

Synonyms (22)

Synonym
sulfonium, ((3s)-3-amino-3-carboxypropyl)dimethyl-, inner salt
methylmethionine
vitamin u
4727-40-6
CHEMBL2074824
s-methylmethionine sulfonium salt
cu vita-u
sulfonium, (3-amino-3-carboxypropyl)dimethyl-, inner salt, (s)-
methyl sulfonium methionine
methionine, methyl sulfonium
3485y39925 ,
unii-3485y39925
CHEBI:67050 ,
s-methyl-l-methioninate
(2s)-2-amino-4-(dimethylsulfonio)butanoate
s-methylmethionine ion
s-methylmethionine [mi]
methylmethionine [inci]
vitamin u [who-dd]
SCHEMBL398004
(2s)-2-amino-4-dimethylsulfoniobutanoate
DTXSID401314761

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" It is apparent that SMM in foods and feeds has methylation bioactivity, and this has implications for proper assessment of dietary Met and choline requirements as well as their bioavailability in foods and feeds."( Dietary S-methylmethionine, a component of foods, has choline-sparing activity in chickens.
Augspurger, NR; Baker, DH; Garrow, TA; Scherer, CS, 2005
)
0.33
" Relative oral bioavailability (RBV) values, with the L-isomer of Met and Cys set at 100% (isosulfurous basis), are near 100% for D-Met for animals but only about 30% for humans."( Comparative species utilization and toxicity of sulfur amino acids.
Baker, DH, 2006
)
0.33

Dosage Studied

ExcerptRelevanceReference
" Vitamin U and its major degradation product in the dosage forms, viz."( Determination of vitamin U and its degradation products by high- performance liquid chromatography with fluorescence detection.
Leung, CP; Leung, WK, 1989
)
0.28
" Even though Cys and its oxidized product (cystine) are equally efficacious at levels at or below their dietary requirements for maximal growth, Cys is far more toxic than cystine when administered orally in the pharmacologic dosing range."( Comparative species utilization and toxicity of sulfur amino acids.
Baker, DH, 2006
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
sulfonium betaineNeutral molecules having charge-separated forms with an sulfonium atom which bears no hydrogen atoms and that is not adjacent to the anionic atom.
methyl-L-methionineA L-methionine derivative carrying methyl substituents at the N or S atom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID682293TP_TRANSPORTER: inhibition of Carnitine uptake (Carnitine: 0.010? uM, S-methylmethionine sufonium: 500 uM) in OCTN2-expressing HEK293 cells1999The Journal of pharmacology and experimental therapeutics, Nov, Volume: 291, Issue:2
Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (165)

TimeframeStudies, This Drug (%)All Drugs %
pre-199069 (41.82)18.7374
1990's25 (15.15)18.2507
2000's24 (14.55)29.6817
2010's31 (18.79)24.3611
2020's16 (9.70)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials7 (3.80%)5.53%
Reviews3 (1.63%)6.00%
Case Studies1 (0.54%)4.05%
Observational0 (0.00%)0.25%
Other173 (94.02%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]